Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10020608
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020608
Fusion event
HBV-CCND1 integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
27339696
Virus Sequence
Virus name
HBV
Reference genome
NC_003977.1
Start
1170
End
2266
Orient
+
Integrated sequence
CTCTGCCAAGTGTTTGCTGACGCAACCCCCACGGGTTGGGGCTTGGCCATAGGCCATCGGCGCATGCGTGGAACCTTTGTGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTC
Host Sequence
Chromosome
chr11
Cytoband
q13.3
Reference genome
GRCh37/hg19
Start
69467075/69652307 (Hg38)
End
69468123/69653355 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA11H
;
FRA11A
Target gene
CCND1
miRNAs that regulate target gene
hsa-mir-20a-5p
;
hsa-mir-195-5p
;
hsa-mir-193b-3p
;
hsa-mir-424-5p
;
hsa-mir-16-1-3p
;
hsa-mir-34a-5p
;
hsa-mir-503-5p
;
hsa-mir-16-5p
;
hsa-mir-15a-5p
;
hsa-let-7b-5p
;
hsa-mir-19a-3p
;
hsa-mir-302a-3p
;
hsa-mir-15b-5p
;
hsa-mir-449a
;
hsa-mir-17-5p
;
hsa-mir-302c-3p
;
hsa-mir-106b-5p
;
hsa-let-7e-5p
;
hsa-mir-365a-3p
;
hsa-mir-19b-1-5p
;
hsa-mir-520b
;
hsa-mir-34b-3p
;
hsa-mir-338-3p
;
hsa-mir-9-5p
;
hsa-mir-374b-5p
;
hsa-mir-425-5p
;
hsa-mir-155-5p
;
hsa-mir-1-3p
;
hsa-mir-183-5p
;
hsa-mir-93-5p
;
hsa-mir-26b-5p
;
hsa-let-7f-5p
;
hsa-mir-196a-5p
;
hsa-mir-92a-3p
;
hsa-mir-138-5p
;
hsa-mir-106a-5p
;
hsa-mir-27a-3p
;
hsa-mir-383-5p
;
hsa-mir-490-3p
;
hsa-mir-603
;
hsa-mir-142-5p
;
hsa-mir-340-5p
;
hsa-mir-448
;
hsa-mir-548k
;
hsa-mir-3609
;
hsa-mir-548ah-5p
;
hsa-mir-3973
;
hsa-mir-5590-3p
;
hsa-mir-548av-5p
;
hsa-mir-8054
;
hsa-mir-6077
;
hsa-mir-214-5p
;
hsa-mir-558
;
hsa-mir-1234-3p
;
hsa-mir-4524a-5p
;
hsa-mir-4694-3p
;
hsa-mir-4524b-5p
;
hsa-mir-1199-3p
;
hsa-mir-6735-3p
;
hsa-mir-6748-3p
;
hsa-mir-6874-5p
;
hsa-mir-7107-5p
;
hsa-mir-497-5p
;
hsa-mir-545-3p
;
hsa-mir-4311
;
hsa-mir-4672
;
hsa-mir-6838-5p
;
hsa-mir-8066
;
hsa-mir-3157-5p
;
hsa-mir-4691-3p
;
hsa-mir-758-5p
;
hsa-mir-374a-5p
;
hsa-mir-4708-5p
;
hsa-mir-4756-3p
;
hsa-mir-193a-3p
;
hsa-mir-4691-5p
;
hsa-mir-6792-3p
;
hsa-mir-655-5p
;
hsa-mir-4709-3p
;
hsa-mir-20b-5p
;
hsa-mir-520a-3p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-491-3p
;
hsa-mir-216b-3p
;
hsa-mir-6500-3p
;
hsa-mir-593-3p
;
hsa-mir-204-3p
;
hsa-mir-494-3p
;
hsa-mir-4261
;
hsa-mir-4646-5p
;
hsa-mir-4666a-5p
;
hsa-mir-4781-3p
;
hsa-mir-708-5p
;
hsa-mir-29a-3p
;
hsa-mir-24-3p
;
hsa-mir-152-3p
;
hsa-mir-206
;
hsa-mir-3907
;
hsa-mir-5196-5p
;
hsa-mir-4747-5p
;
hsa-mir-5589-5p
;
hsa-mir-4731-5p
;
hsa-mir-7706
;
hsa-mir-5706
;
hsa-mir-4782-5p
;
hsa-mir-516b-5p
;
hsa-mir-1299
;
hsa-mir-563
;
hsa-mir-380-5p
;
hsa-mir-1193
;
hsa-mir-8069
;
hsa-mir-4537
;
hsa-mir-202-3p
;
hsa-mir-2392
;
hsa-let-7c-5p
;
hsa-let-7g-5p
;
hsa-let-7a-5p
;
hsa-let-7d-5p
;
hsa-mir-4500
;
hsa-mir-98-5p
;
hsa-let-7i-5p
;
hsa-mir-4458
;
hsa-mir-6848-3p
;
hsa-mir-6843-3p
;
hsa-mir-3191-5p
;
hsa-mir-513a-5p
;
hsa-mir-7112-3p
;
hsa-mir-6875-5p
;
hsa-mir-3126-5p
;
hsa-mir-1253
;
hsa-mir-3663-5p
;
hsa-mir-6824-3p
;
hsa-mir-6764-3p
;
hsa-mir-330-5p
;
hsa-mir-326
;
hsa-mir-7845-5p
;
hsa-mir-518c-5p
;
hsa-mir-9500
;
hsa-mir-6873-5p
;
hsa-mir-5197-3p
;
hsa-mir-95-3p
;
hsa-mir-6500-5p
;
hsa-mir-4633-3p
;
hsa-mir-574-5p
;
hsa-mir-5010-3p
;
hsa-mir-147a
;
hsa-mir-6818-5p
;
hsa-mir-6867-5p
;
hsa-mir-223-5p
;
hsa-mir-5087
;
hsa-mir-298
;
hsa-mir-4748
;
hsa-mir-4464
;
hsa-mir-6511a-5p
;
hsa-mir-1910-3p
;
hsa-mir-3714
;
hsa-mir-548an
;
hsa-mir-96-5p
;
hsa-mir-1271-5p
;
hsa-mir-593-5p
;
hsa-mir-145-3p
;
hsa-mir-676-5p
;
hsa-mir-5009-3p
;
hsa-mir-4715-5p
;
hsa-mir-541-5p
;
hsa-mir-3591-3p
;
hsa-mir-21-3p
;
hsa-mir-556-5p
;
hsa-mir-4796-3p
;
hsa-mir-891b
;
hsa-mir-5692c
;
hsa-mir-5692b
;
hsa-mir-369-3p
;
hsa-mir-944
;
hsa-mir-1257
;
hsa-mir-323b-3p
;
hsa-mir-646
;
hsa-mir-6768-5p
;
hsa-mir-4746-3p
;
hsa-mir-3648
;
hsa-mir-875-3p
;
hsa-mir-4797-5p
;
hsa-mir-466
;
hsa-mir-3941
;
hsa-mir-4643
;
hsa-mir-4735-3p
;
hsa-mir-4789-3p
;
hsa-mir-18b-5p
;
hsa-mir-18a-5p
;
hsa-mir-3189-5p
;
hsa-mir-4758-3p
;
hsa-mir-5699-5p
;
hsa-mir-1915-5p
;
hsa-mir-6884-3p
;
hsa-mir-3922-5p
;
hsa-mir-2861
;
hsa-mir-34a-3p
;
hsa-mir-3940-5p
;
hsa-mir-34c-5p
;
hsa-mir-101-3p
;
hsa-mir-146a-5p
;
hsa-mir-576-3p
;
hsa-mir-211-5p
;
hsa-let-7a-3p
;
hsa-mir-892b
;
hsa-mir-1243
;
hsa-mir-1273f
;
hsa-mir-1276
;
hsa-mir-1293
;
hsa-mir-224-5p
;
hsa-mir-3147
;
hsa-mir-3148
;
hsa-mir-3153
;
hsa-mir-3170
;
hsa-mir-3179
;
hsa-mir-3202
;
hsa-mir-323a-5p
;
hsa-mir-342-5p
;
hsa-mir-3919
;
hsa-mir-432-3p
;
hsa-mir-4425
;
hsa-mir-4483
;
hsa-mir-4533
;
hsa-mir-4651
;
hsa-mir-4664-5p
;
hsa-mir-4716-3p
;
hsa-mir-4720-3p
;
hsa-mir-4804-3p
;
hsa-mir-5572
;
hsa-mir-5587-5p
;
hsa-mir-608
;
hsa-mir-625-5p
;
hsa-mir-651-3p
;
hsa-mir-653-3p
;
hsa-mir-668-3p
;
hsa-mir-6733-5p
;
hsa-mir-6737-5p
;
hsa-mir-6739-5p
;
hsa-mir-6747-5p
;
hsa-mir-6794-5p
;
hsa-mir-6812-5p
;
hsa-mir-6819-5p
;
hsa-mir-6855-5p
;
hsa-mir-6885-3p
;
hsa-mir-8068
;
hsa-mir-8080
;
hsa-mir-876-3p
;
hsa-mir-3135a
;
hsa-mir-4666a-3p
;
hsa-mir-4803
Nearest miRNA
hsa-mir-10392/Upstream/569049; hsa-let-7a-2/Downstream/630600;
Nearest TSS
ENST00000527297/Upstream/4350;
ENST00000534086/Downstream/5075;
Nearest CpG islands
None/Target,
chr11-CpG: 30/Upstream/5697
,
chr11-CpG: 25/Downstream/687
Nearest cancer related gene
CCND1
(OG, No orient, 0)
Upstream sequence
ttctgttctggatctcaaacatgctttctttactattcctttgcacccttcatcccagcctctcttcgctttcacttggactgacccggacacccatcag
Downstream sequence
ATACTGCCATGTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCTTTTTTGTAGTTTTTTTTTTTTTTATGTGATCAATTTTGACTTAAT
Target sequence
CAATAGGTGTAGGAAATAGCGCTGTTTTTGTTGTGTGTGCAGGGAGGGCAGTTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCAAGCAGGACTTTGAGGCAAGTGTGGGCCACTGTGGTGGCAGTGGAGGTGGGGTGTTTGGGAGGCTGCGTGCCAGTCAAGAAGAAAAAGGTTTGCATTCTCACATTGCCAGGATGATAAGTTCCTTTCCTTTTCTTTAAAGAAGTTGAAGTTTAGGAATCCT
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Sample Information
×
Sample name
TCGA-UB-A7MC-01A-11R-A33R-07
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate